Loading...

Tekla Life Sciences Investors

HQLNYSE
Financial Services
Asset Management
$12.81
$0.03(0.23%)

Tekla Life Sciences Investors HQL Peers

See (HQL) competitors and their performances in Stock Market.

Peer Comparison Table: Asset Management Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
HQL$12.81+0.23%370.1M-26.71-$0.48+14.81%
VFINX$572.69+0.77%1.5T26.90$21.24+1.23%
VOO$568.03+0.19%1.5T26.95$21.07+1.23%
VITSX$148.03+0.71%1.3T26.13$5.65+1.32%
VTSAX$148.01+0.71%1.3T26.13$5.65+1.23%
FXAIX$216.11+1.06%655.7BN/AN/AN/A
VTI$303.93+0.20%630.2B26.19$11.61+1.23%
IVV$620.90+0.56%595.3B26.71$23.24+1.29%
SPY$617.85+0.48%567.1B26.71$23.13+1.16%
VTSNX$148.37+0.69%506.9B16.50$8.97+2.83%
Showing 1 to 10 of 100 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

HQL vs VFINX Comparison

HQL plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HQL stands at 370.1M. In comparison, VFINX has a market cap of 1.5T. Regarding current trading prices, HQL is priced at $12.81, while VFINX trades at $572.69.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HQL currently has a P/E ratio of -26.71, whereas VFINX's P/E ratio is 26.90. In terms of profitability, HQL's ROE is +0.19%, compared to VFINX's ROE of +0.00%. Regarding short-term risk, HQL is more volatile compared to VFINX. This indicates potentially higher risk in terms of short-term price fluctuations for HQL.

Stock Price Comparison

Loading...

Frequently Asked Questions

;